Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 28.9% in First Three Quarters of 2022

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 589.2 million yuan in the first three quarters of 2022, down 28.9% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 21.6% year-on-year.

At the end of the reporting period, it had 9.9 billion yuan in total assets and 403.6 million yuan in total liabilities, with a liability-to-asset ratio of 4.1%.